Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-07

Clinical Trial Update: The Effect of Semaglutide on the Intestinal Flora in Obesity

View source ↗

Summary

A clinical trial evaluating the effect of semaglutide on the intestinal microbiota in obesity, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • semaglutide (semaglutide)

Snippet

Sponsor: Beijing Chao Yang Hospital | Conditions: Obesity | Status: NOT_YET_RECRUITING